Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-05

Clinical Trial Update: Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update shows completion of oxcarbazepine for chronic peripheral neuropathic pain, including polyneuropathy, peripheral nerve injury, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Søren H. Sindrup | Conditions: Polyneuropathy, Peripheral Nerve Injury | Phase 4 | Status: COMPLETED